Detalhe da pesquisa
1.
VRK1 Is a Synthetic-Lethal Target in VRK2-Deficient Glioblastoma.
Cancer Res
; 82(21): 4044-4057, 2022 11 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36069976
2.
Sustained mTORC1 activity during palbociclib-induced growth arrest triggers senescence in ER+ breast cancer cells.
Cell Cycle
; 20(1): 65-80, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33356791
3.
Mutant GATA3 Actively Promotes the Growth of Normal and Malignant Mammary Cells.
Anticancer Res
; 38(8): 4435-4441, 2018 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-30061207
4.
Purine Nucleotide Availability Regulates mTORC1 Activity through the Rheb GTPase.
Cell Rep
; 19(13): 2665-2680, 2017 06 27.
Artigo
Inglês
| MEDLINE | ID: mdl-28658616